Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT00866281 |
| Title | A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | child |
| Covered Countries | USA | NLD | ITA | FRA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Seattle Children's Hospital CPKC412A2114 | Seattle | Washington | 98105 | United States | Details | |
| Novartis Investigative Site | Paris Cedex 19 | 75935 | France | Details | ||
| Novartis Investigative Site | Genova | GE | 16147 | Italy | Details | |
| Novartis Investigative Site | Monza | MB | 20900 | Italy | Details | |
| Novartis Investigative Site | Roma | RM | 00165 | Italy | Details | |
| Novartis Investigative Site | Torino | TO | 10126 | Italy | Details | |
| Novartis Investigative Site | Rotterdam | 3015 GJ | Netherlands | Details | ||
| Novartis Investigative Site | Stockholm | SE-171 76 | Sweden | Details |